Investor roadshow presentation and business update
Filed with ASX · · 27 pages · English
Melbourne, Victoria – Alcidion Group Limited (ASX: ALC) today advises it has released the attached investor presentation and business update, which will be presented to investors this week by Managing Director Kate Quirke. Highlights from the presentation include: • Two contracts signed in Q3 since the release of the Appendix 4C, adding a further $1 million of sold revenue to be recognised in FY20
In the deck
Earlier from Alcidion
- Appendix 4C - quarterly
- Alcidion signs contract for medications management solution
- 3-year deal signed with digital exemplar NHS trust Taunton
- ALC Raises $16.2m via Placement to Institutional Investors
- Partnership signed with Healthscope for data and analytics
Later from Alcidion
- Alcidion FY20 Half Year Report and Appendix 4D
- Shareholder Update
- Alcidion appoints healthcare executive Steve Lutz as General Manager of Business Development for ANZ
- NHS Fife extends Patientrack across Board
- Q3 FY2020 Business Update and Appendix 4C
Follow Alcidion into a list and get an email when it puts out news.
Follow Alcidion